Cambridge Cognition Holdings PLC (LON:COG)‘s stock had its “corporate” rating restated by equities researchers at FinnCap in a research report issued to clients and investors on Thursday. They presently have a GBX 115 ($1.50) target price on the stock. FinnCap’s price target would suggest a potential upside of 42.86% from the stock’s previous close.
Shares of Cambridge Cognition Holdings PLC (LON:COG) opened at 80.50 on Thursday. The firm’s market capitalization is GBX 15.01 million. The company has a 50-day moving average price of GBX 60.86 and a 200-day moving average price of GBX 45.31. Cambridge Cognition Holdings PLC has a 12-month low of GBX 30.00 and a 12-month high of GBX 105.00.
Cambridge Cognition Holdings PLC Company Profile
Cambridge Cognition Holdings plc is a holding company. The Company operates through its wholly owned subsidiary, Cambridge Cognition Limited (CCL). It develops and commercializes computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company has three segments: Healthcare, which includes medical software for use in healthcare delivery settings; Academic Research, which includes cognitive test products for researchers working in a non-regulated environment, and Clinical Trials, which includes products and services for use in regulated pharmaceutical clinical trials.
Receive News & Ratings for Cambridge Cognition Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition Holdings PLC and related companies with MarketBeat.com's FREE daily email newsletter.